tiprankstipranks
Advertisement
Advertisement
Neurotech Director Mark Davies Increases Indirect Shareholding
PremiumCompany AnnouncementsNeurotech Director Mark Davies Increases Indirect Shareholding
3M ago
Neurotech clears secondary trading for new share issue
Premium
Company Announcements
Neurotech clears secondary trading for new share issue
3M ago
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares
Premium
Company Announcements
Neurotech International Seeks ASX Quotation for 21.4 Million New Shares
3M ago
Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
PremiumCompany AnnouncementsNeurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
4M ago
Neurotech International Calls March General Meeting, Moves to Digital Meeting Notices
Premium
Company Announcements
Neurotech International Calls March General Meeting, Moves to Digital Meeting Notices
5M ago
Neurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164
Premium
Company Announcements
Neurotech Wins Ethics Approval for Pivotal Phase 3 Autism Trial of NTI164
5M ago
Neurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
PremiumCompany AnnouncementsNeurotech Director’s 5 Million Options Lapse, Reducing Potential Equity Exposure
6M ago
Neurotech Options Lapse, Streamlining Capital Structure
Premium
Company Announcements
Neurotech Options Lapse, Streamlining Capital Structure
6M ago
Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments
Premium
Company Announcements
Neurotech International Secures $4 Million to Advance Paediatric Neurological Treatments
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100